Search Results
Apr 27, 2026, 08:00 ET RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
(Bekinda)11 update:RHB-102 (Bekinda) is a proprietary, advanced clinical-stage, once-daily, bimodal extended-release, oral tablet formulation of 5-HT3 antagonist, ondansetron, targeting oncology support, acute gastroenteritis and gastritis, IBS-D and GLP-1/GIP-associated gastrointestinal
More news about: RedHill Biopharma Ltd.
Apr 27, 2026, 06:17 ET Yokohama Tire's New GEOLANDAR H/T4™: Rugged Reliability Meets the Open Road
multimedia:https://www.prnewswire.com/news-releases/yokohama-tires-new-geolandar-ht4-rugged-reliability-meets-the-open-road-302752278.htmlSOURCE
More news about: Yokohama Tire Corp.
Apr 22, 2026, 09:00 ET Johnson Controls' 2026 sustainability report highlights energy efficiency returns in mission-critical industries
high-efficiency cooling, thermal management, controls, security and fire protection systems including the YORK YDAM magnetic bearing chiller, the YORK YK-HT two-stage economized centrifugal chiller, the Silent-Aire Coolant Distribution Unit platform, and the Metasys building automation system, which continuously
More news about: Johnson Controls International plc
Apr 21, 2026, 16:13 ET 2026 Long Drive Rebate: New Rebate from Hankook Tire Offers Up to $100 Savings
in all weather and road conditions, including the new Dynapro evo AS and Dynapro HT2. For drivers looking for tires for their high-performance SUVs, the Dynapro evo AS provides all-season durability, while the Dynapro HT2 offers year-round comfort on the highway.As Hankook Tire continues innovating
More news about: Hankook Tire America Corp.
Apr 21, 2026, 04:00 ET BrightCharger and Endrich sign licensing agreement to expand BrightZero® charging control to new components and products
standby-type energy use after charging is complete.The first upcoming step in the collaboration is a BrightZero-enabled version of Holtek's HT45F9160 Power Delivery Flash MCU. This opens a practical new PD chip path for charger makers. Together with an OEM Integration Guideline and a first
More news about: BrightCharger OY
Apr 21, 2026, 04:00 ET BrightCharger und Endrich unterzeichnen Lizenzvereinbarung zur Erweiterung der BrightZero®-Ladesteuerung auf neue Komponenten und Produkte
nach Abschluss des Ladevorgangs zu verringern.Der erste anstehende Schritt der Zusammenarbeit ist eine BrightZero-enabled-Version von Holteks HT45F9160 Power Delivery Flash MCU. Dies eröffnet einen praktikablen neuen PD-Chip-Pfad für Ladegerätehersteller. Zusammen mit einer OEM Integration
More news about: BrightCharger OY
Apr 20, 2026, 16:15 ET CPC Biotech Launches Versatile AseptiQuik G Connector
Schweitz, Product Manager, CPC Biotech. "The new AseptiQuik G PPSU HT connectors meet these performance needs and work seamlessly with previous generations of AseptiQuik G products."A gold-colored tab distinguishes the new PPSU HT connectors from earlier AseptiQuik polycarbonate (blue or white tabs)
More news about: Dover
Apr 20, 2026, 16:15 ET MATSON TO ANNOUNCE FIRST QUARTER 2026 RESULTS ON MAY 4, 2026
Time:4:30 p.m. ET / 1:30 p.m. PT / 10:30 a.m. HTThe conference call will be broadcast live along with an additional slide presentation on the Company's website at
More news about: Matson, Inc.
Apr 20, 2026, 03:09 ET Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
methods.In addition, the company's self-developed ARGO™ HT fully automated, high-throughput system enables a "sample-to-answer" automated workflow, driving rapid growth in product market penetration. As of the end of 2025, the ARGO™ HT system had accumulated an installed base of over 100 instruments,
More news about: Qiming Venture Partners
Apr 19, 2026, 22:41 ET Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
methods.In addition, the company's self-developed ARGO™ HT fully automated, high-throughput system enables a "sample-to-answer" automated workflow, driving rapid growth in product market penetration. As of the end of 2025, the ARGO™ HT system had accumulated an installed base of over 100 instruments,
More news about: Qiming Venture Partners
Apr 14, 2026, 08:00 ET Scopio Labs Secures EU IVDR Certification for the Industry-Only Full-Field Digital Bone Marrow Application
announced it has achieved IVDR certification for its Full-Field Bone Marrow Aspirate (FF-BMA) Application. This milestone, covering both the X100 and X100HT platforms, solidifies Scopio's position as the only provider of high-throughput, Full-Field digital imaging at 100x for the most complex diagnostic procedures
More news about: Scopio Labs
Apr 14, 2026, 07:00 ET Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
activating fat metabolism differentiates GDNF from existing therapies, including GLP-1 agonists."SCIENTIFIC SUMMARY (HT-VA STUDY)The HT-VA study evaluated the effects of parenteral GDNF in a diet-induced obesity and MAFLD model.Key observations include:
More news about: Hoth Therapeutics, Inc.
Apr 13, 2026, 17:23 ET Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
activating fat metabolism differentiates GDNF from existing therapies, including GLP-1 agonists."SCIENTIFIC SUMMARY (HT-VA STUDY)The HT-VA study evaluated the effects of parenteral GDNF in a diet-induced obesity and MAFLD model.Key observations include:
More news about: Hoth Therapeutics, Inc.
Apr 13, 2026, 03:43 ET Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
present primary 12-month results from the open-label extension of the Phase 1b/2a PACIFIC trial evaluating bexicaserin, an investigational selective 5-HT2C receptor superagonist being studied for the treatment of seizures in DEEs, including Dravet syndrome and Lennox-Gastaut syndrome.Separately,
More news about: H. Lundbeck A/S
Apr 13, 2026, 03:40 ET Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
present primary 12-month results from the open-label extension of the Phase 1b/2a PACIFIC trial evaluating bexicaserin, an investigational selective 5-HT2C receptor superagonist being studied for the treatment of seizures in DEEs, including Dravet syndrome and Lennox-Gastaut syndrome.Separately,
More news about: H. Lundbeck A/S
Apr 01, 2026, 12:38 ET GAC Debuts Four Flagship Pure Electric Models in Ethiopia - GAC JUNTU Flagship Showroom Officially Opens
wealth of global layout experience. The four pure electric models unveiled in the Ethiopian market this time cover AION UT, SUV AION V HOME, SUV HYPTEC HT, and SUV HYPTEC HL, forming a comprehensive product matrix that perfectly adapts to diverse scenarios and fully meets the mobility needs of different
More news about: GAC
Apr 01, 2026, 08:14 ET Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week Six
receiving HT-001, highlighting the potential for HT-001 to manage dermatologic side effects without interfering with life-saving cancer treatments.HT-001 was also well tolerated, with no treatment discontinuations reported.Pharmacokinetic (PK) analysis further demonstrated that HT-001 achieves
More news about: Hoth Therapeutics, Inc.
Mar 27, 2026, 12:23 ET GAC Philippines procède à trois changements stratégiques avec ONE GAC 2.0 pour renforcer sa présence sur le marché local
février dans son showroom de Makati, invitant les médias spécialisés dans l'automobile et les principaux leaders d'opinion à découvrir l'AION V et l'HYPTEC HT grâce à des essais routiers approfondis et de la cocréation de contenu.Étape clé dans la série d'activités de renouvellement de la marque, la
More news about: GAC
Mar 27, 2026, 11:45 ET GAC Filipinas realiza três movimentos estratégicos com ONE GAC 2.0 para aprofundar presença no mercado local
dias no início de fevereiro em seu showroom em Makati, convidando a mídia automotiva e líderes de opinião importantes a vivenciar o AION V e o HYPTEC HT por meio de testes aprofundados e cocriação de conteúdo.Como um marco fundamental na série de atividades de renovação de marcas, a Conferência
More news about: GAC
Mar 27, 2026, 11:32 ET GAC Filipinas presenta tres movimientos estratégicos con ONE GAC 2.0 para ampliar su presencia en el mercado local
de contenido) durante dos días, e invitó a la prensa especializada en el sector automotriz y a líderes de opinión a experimentar el AION V y el HYPTEC HT a través de amplias pruebas de conducción y creación conjunta de contenido.Como un importante hito en la serie de actividades de renovación de
More news about: GAC
Mar 27, 2026, 08:00 ET Otsuka Pharmaceutical to Acquire Transcend Therapeutics
synaptic cleft, resulting in rapid and sustained enhancement of neuroplasticity.3,4 Importantly, TSND-201 does not act on the serotonin 5-HT2A receptor, which mediates hallucinogenic effects, and is therefore considered a non-hallucinogenic compound.3,5Transcend is also conducting
More news about: Otsuka Pharmaceutical Co.; Transcend Therapeutics
Mar 26, 2026, 11:17 ET GAC Filipinas da tres pasos estratégicos con ONE GAC 2.0 para afianzar su presencia en el mercado local
de Makati, invitando a medios de comunicación especializados en el sector automotriz y a líderes de opinión clave a experimentar el AION V y el HYPTEC HT mediante pruebas de conducción exhaustivas y la creación conjunta de contenido.Como hito clave en la serie de actividades de renovación
More news about: GAC
Mar 26, 2026, 11:16 ET GAC Philippines setzt mit „ONE GAC 2.0" drei strategische Maßnahmen um, um seine Präsenz auf dem lokalen Markt zu stärken
Februar einen zweitägigen „Content Day" in seinem Showroom in Makati und lud Automobilmedien sowie wichtige Meinungsführer ein, den AION V und den HYPTEC HT durch ausführliche Testfahrten und die gemeinsame Erstellung von Inhalten zu erleben.Als wichtiger Meilenstein in der Reihe der Aktivitäten zur
More news about: GAC
Mar 26, 2026, 11:11 ET The new Broadband Battery from GS Yuasa Energy Solutions Provides High Performance and Long Life Even in the Hottest Climates
Telecom (PWL/PYL) and UPS (SWU) Series products," said Bill Moll, President of GYES. "The HT X Alloy used across our product portfolio delivers the long service life demanded in these high‑temperature environments."HT X Alloy maintains tightly controlled trace elements that extend lifespan in high temperature
More news about: GS Yuasa Energy Solutions, Inc.
Mar 26, 2026, 10:05 ET Household Insecticides Market to Reach US$ 31.7 Billion by 2033 Expands Amid Rising Health Concerns and Urban Living Trends - Persistence Market Research
Binders, Biological Binders, Composite/Hybrid Binders), by Mycotoxin Type (Aflatoxins, Ochratoxins, Fumonisins, Zearalenone, Deoxynivalenol, T-2 & HT-2 Toxins, Others), by Form (Powder, Granules, Liquid, Pellets), by Application (Animal Feed, Food & Beverages, Pet Food, Aquaculture, Others), by
More news about: Persistence Market Research Pvt. Ltd.